Neus Agell

Departament de Salut — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index5.5kcitations156works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(41), Cancer-related Molecular Pathways(32), Protein Kinase Regulation and GTPase Signaling(26), Ubiquitin and proteasome pathways(23), Microtubule and mitosis dynamics(16)

Publications156 total

Epigenetic regulation of serine biosynthesis by PHF8 during neurogenesis
EMBO Reports·2026Open Access
Adaptive replication origin activation alters chromatin dynamics and stability in cancer cells
2024Open Access
Crucial role of the NSE1 RING domain in Smc5/6 stability and FANCM-independent fork progression
Cellular and Molecular Life Sciences·2024· 5 citedOpen Access
Supplementary Figure 7 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 2 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 5 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Tables 1 - 3 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Figure 5 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Data from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Figure 6 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 7 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 6 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 4 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Tables 1 - 3 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Figure 3 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 3 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Figure 6 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Supplementary Figure 3 from Phosphorylation at Ser-181 of Oncogenic KRAS Is Required for Tumor Growth
2023Open Access
Data from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
Supplementary Figure 4 from Different S/M Checkpoint Responses of Tumor and Non–Tumor Cell Lines to DNA Replication Inhibition
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Oriol Bachs(26), Marta Llovera(13), Francisco J. López‐Soriano(13), Cèlia Garcı́a-Martı́nez(12), Josep M. Argilés(12), Josep Marı́a Estanyol(8), Priam Villalonga(6), Montserrat Jaumot(6), Cristina López-Alcalá(5), Núria Canela-Canela(5), Aina Rodríguez‐Vilarrupla(5), María Jesús Pujol(5), Oriol Casanovas(4), Neus Carbó(4), Blanca Alvarez-Moya(4), Gabriel Capellá(3), Joan Gil(3), C. Díaz(3), Paola Costelli(3), Marı́a Calvo(3)